Overview

Dexmedetomidine and Subarachnoid Haemorrhage

Status:
Completed

Trial end date:
2016-12-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate how dexmedetomidine affects static and dynamic autoregulation, intracranial pressure (ICP) and cerebral oxygenation in aneurysmal subarachnoid haemorrhage (SAH) patients.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Turku University Hospital

Collaborator:

Orion Corporation, Orion Pharma

Treatments:

Dexmedetomidine